Artificial intelligence-enabled target discovery: decoding cardiometabolic pathways from omics to mechanism

31 August 2026 (14:15 - 14:30)

Organised by:

Video

Slides

Sign in for access options

About the speaker

Doctor Marcus Kelm

Charité - University Medicine Berlin, Berlin (Germany)

3 More presentations in this session

Presentation thumbnail

Digital trials: how artificial intelligence optimises phenotyping, recruitment, and adaptive designs in cardiometabolic therapeutics

Doctor S. Niederer (London, GB)

Presentation thumbnail

Regulatory science meets artificial intelligence: pathways for approval of artificial intelligence-developed cardiometabolic drugs

Professor P. Szymanski (Warszawa, PL)

Presentation thumbnail

Artificial intelligence in cardiometabolic drug discovery: from molecular insight to regulatory approval - discussion

Access the full session

Session thumbnail

Artificial intelligence in cardiometabolic drug discovery: from molecular insight to regulatory approval

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET

You may be interested in

Congress Presentation

How artificial intelligence is transforming cardiovascular metabolism research through multiomics integration

29 August 2026

Congress Presentation

Machine learning–based proteomic phenogrouping identifies an inflammatory high-risk subtype in HFpEF : results from the PACIFIC-PRESERVED study

30 August 2026

Congress Session

Omics in heart failure: from biomarker to new therapeutic targets

22 May 2022

Congress Session

Late-Breaking Clinical Science on heart failure: diagnosis and prognosis registries

28 August 2026

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources